1
/
of
1
Equine IGF2 (Insulin-like Growth Factor 2) ELISA Kit
Equine IGF2 (Insulin-like Growth Factor 2) ELISA Kit
The Equine (IGF2) Insulin-like Growth Factor 2 ELISA Kit measures Insulin-like Growth Factor 2 in Equine samples. The plate has been pre-coated with Equine IGF2 antibody. IGF2 present in the sample is added and binds to antibodies coated on the wells. And then biotinylated Equine IGF2 Antibody is added and binds to IGF2 in the sample. Then Streptavidin-HRP is added and binds to the Biotinylated IGF2 antibody. After incubation unbound Streptavidin-HRP is washed away during a washing step. Substrate solution is then added and color develops in proportion to the amount of Equine IGF2. The reaction is terminated by addition of acidic stop solution and absorbance is measured at 450 nm.
Catalog No:
E0127HO
Regular price
$647.00 USD
Regular price
$498.00 USD
Sale price
$647.00 USD
Unit price
/
per
2.5 weeks
Couldn't load pickup availability
Product Details
Species Reactivity
Equine
Sensitivity
0.095 ng/mL
Detection Range
0.2-70 ng/mL
Sample Type
Serum, plasma, cell culture supernates
Incubation(s)
1.5 hour(s)
Research Areas
Signal Transduction, Cancer, Developmental Biology, Diabetes Research, Endocrinology, Metabolism
Background
The Insulin-like growth factors possess growth-promoting activity (By similarity). Major fetal growth hormone in mammals. Plays a key role in regulating fetoplacental development. IGF2 is influenced by placental lactogen. Also involved in tissue differentiation. In adults, involved in glucose metabolism in adipose tissue, skeletal muscle and liver. Acts as a ligand for integrin which is required for IGF2 signaling. Positively regulates myogenic transcription factor MYOD1 function by facilitating the recruitment of transcriptional coactivators, thereby controlling muscle terminal differentiation (By similarity). Inhibits myoblast differentiation and modulates metabolism via increasing the mitochondrial respiration rate (By similarity). Preptin undergoes glucose-mediated co-secretion with insulin, and acts as physiological amplifier of glucose-mediated insulin secretion. Exhibits osteogenic properties by increasing osteoblast mitogenic activity through phosphoactivation of MAPK1 and MAPK3. Source: UniProt Consortium (2025)
Shipping Condition
Shipped on cold gel packs.
Storage Condition and Shelf Life
2-8C
Analyte
Insulin-like Growth Factor 2
Regulatory Status
For Research Use Only
